PRESS RELEASES

Featured post

February 21, 2023

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Announces Fourth Quarter 2022 Results

Read more »

Featured post

February 07, 2023

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences Launches OncoExTra Cancer Therapy Selection Test in the U.S.

Read more »

Featured post

February 01, 2023

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Read more »

February 21, 2023

Exact Sciences Announces Fourth Quarter 2022 Results
February 07, 2023

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
February 01, 2023

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027
January 08, 2023

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
January 07, 2023

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test
December 09, 2022

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
December 06, 2022

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022
November 03, 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
October 24, 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting
September 22, 2022

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations
September 10, 2022

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress
August 02, 2022

Exact Sciences Announces Second Quarter 2022 Results

Multimedia

VIDEOS

PHOTOS

Choose your country or region:

PRESS RELEASES

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

Exact Sciences Announces Second Quarter 2022 Results

Multimedia

Quick Links

Choose your country or region:

PRESS RELEASES

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

Exact Sciences Announces Second Quarter 2022 Results

Multimedia

Quick Links

Follow us on

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022